Walking and tSCS in Non-ambulatory Stroke Survivors

This study is looking at new ways to help people who have had a stroke and have trouble walking. It compares two approaches: robot-assisted gait training alone, and robot-assisted gait training combined with transcutaneous spinal cord stimulation (tSCS). tSCS is a novel therapy that may improve outcomes. The goal is to see if adding tSCS helps people walk better after a stroke. Researchers will measure changes in cardiac output (how much blood your heart pumps) to see if the treatments are successful. You might be able to join if you are 18-80 years old, had a stroke at least six months ago, and have difficulty walking. The study plans to enroll 20 participants, but its current status is unclear.

Study design
This is an interventional pilot study comparing two groups of participants. It plans to enroll 20 participants.
What's involved
Participants will receive 30 minutes of robot-assisted gait training, three times per week, for 8 weeks, totaling 24 sessions.
Compensation
Not stated in the trial record.
Follow-up
Cardiac output will be measured before and after 24 training sessions (8 weeks).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07226518

Walking and tSCS in Non-ambulatory Stroke Survivors

Not Yet Recruiting
NAAges 18–80Interventional
University of Kansas Medical Center
~20 participants
Updated 2025-11-10 on ClinicalTrials.gov
What's tested:Robot-assisted gait training and transcutaneous spinal cord stimulation in chronic non-ambulatory stroke survivors: pilot RCT trialRobot assisted gait training alone

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cardiac Output (Measured by Impedance Cardiography - BIOPAC MP160 System)
Measured over Before and after 24 training sessions (8 weeks)
Chronic Stroke Survivors
Chronic Stroke Patients
Stroke

NCT07226518

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Neuromuscular Research Laboratory

    Kansas City, Kansasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Wen Liu, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Cardiac Output (Measured by Impedance Cardiography - BIOPAC MP160 System)Before and after 24 training sessions (8 weeks)

    Cardiac output (L/min) will be measured using an impedance cardiography system (MP160, BIOPAC Systems Inc., Goleta, California). Measurements will be done during a 6-minute walk test. Data collection for each participant will occur at approximately the same time of day (between 9:00 AM and 11:00 AM) before the first intervention session and after completion of the 24th intervention session.